nach oben

Erschienen in:

06.12.2019 | Original Paper

Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II

verfasst von: Dennis Lawin, Carsten W. Israel, Cecilia Linde, Camilla Normand, Kenneth Dickstein, Christiane Lober, Anselm K. Gitt, Gerhard Hindricks, Christoph Stellbrink, for the members of the European CRT Survey II of the EHRA/HFA/ESC

Erschienen in: Clinical Research in Cardiology | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The European CRT Survey II was introduced to offer insights into CRT implantation practice in Europe. We compared the national data from the participating German centres with that of the other European countries with regard to differences in patient selection, implant results, and initial properties.

Methods and results

11,088 patients were enrolled in 288 centres from 42 countries between 2015 and 2017. Of these, 675 (6.1%) were included in 17 centres in Germany. Patients from Germany were older, had more comorbidities and more symptoms of heart failure (HF) than patients from other European countries. There were no differences with regard to HF aetiology and guideline-directed medical treatment was overall well implemented. There was a high use of CRT in patients with atrial fibrillation, even higher in German patients. CRT was most often applied due to HF with wide QRS complex (class I recommendation) but with relatively higher frequency in Germany due to HF with primary indication for an implantable cardioverter-defibrillator (class IIb) or a pacemaker with expected pacing dependency (class I). The overall implant success rate was high with some differences in the implant procedure. The use of remote monitoring was lower in Germany.

Conclusion

This analysis from the European CRT Survey II overall shows good guideline adherence, high implantation success and a low rate of complications in daily practice. There are some regional differences in baseline characteristics, CRT indication, and procedural aspects. The use of remote monitoring in Germany lags behind other European countries.

Graphic abstract

Cazeau S, Leclercq C, Lavergne T et al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880. https://doi.org/10.1056/NEJM200103223441202 CrossRefPubMed

Cazeau S, Ritter P, Bakdach S et al (1994) Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 17:1974–1979CrossRef

Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853. https://doi.org/10.1056/NEJMoa013168 CrossRefPubMed

Cleland JGF, Daubert J-C, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549. https://doi.org/10.1056/NEJMoa050496 CrossRefPubMed

Cleland JG, Abraham WT, Linde C et al (2013) An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J 34:3547–3556. https://doi.org/10.1093/eurheartj/eht290 CrossRefPubMedPubMedCentral

Goldenberg I, Kutyifa V, Klein HU et al (2014) Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med 370:1694–1701. https://doi.org/10.1056/NEJMoa1401426 CrossRefPubMed

Linde C, Abraham WT, Gold MR et al (2008) Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52:1834–1843. https://doi.org/10.1016/j.jacc.2008.08.027 CrossRefPubMed

Moss AJ, Hall WJ, Cannom DS et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338. https://doi.org/10.1056/NEJMoa0906431 CrossRefPubMed

Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975. https://doi.org/10.1002/ejhf.592 CrossRefPubMed

10.

Dickstein K, Bogale N, Priori S et al (2009) The European cardiac resynchronization therapy survey. Eur Heart J 30:2450–2460. https://doi.org/10.1093/eurheartj/ehp359 CrossRefPubMed

11.

Dickstein K, Normand C, Anker SD et al (2015) European Cardiac Resynchronization Therapy Survey II: rationale and design. Europace 17:137–141. https://doi.org/10.1093/europace/euu312 CrossRefPubMed

12.

Dickstein K, Normand C, Auricchio A et al (2018) CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11,088 patients-who is doing what to whom and how? Eur J Heart Fail 20:1039–1051. https://doi.org/10.1002/ejhf.1142 CrossRefPubMed

13.

Abraham WT, Young JB, León AR et al (2004) Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 110:2864–2868. https://doi.org/10.1161/01.CIR.0000146336.92331.D1 CrossRefPubMed

14.

Cleland JGF, Freemantle N, Erdmann E et al (2012) Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Eur J Heart Fail 14:628–634. https://doi.org/10.1093/eurjhf/hfs055 CrossRefPubMed

15.

Young JB, Abraham WT, Smith AL et al (2003) Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289:2685–2694. https://doi.org/10.1001/jama.289.20.2685 CrossRefPubMed

16.

Delnoy PPHM, Ottervanger JP, Luttikhuis HO et al (2007) Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 99:1252–1257. https://doi.org/10.1016/j.amjcard.2006.12.040 CrossRefPubMed

17.

Gasparini M, Auricchio A, Regoli F et al (2006) Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 48:734–743. https://doi.org/10.1016/j.jacc.2006.03.056 CrossRefPubMed

18.

Leclercq C, Walker S, Linde C et al (2002) Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 23:1780–1787. https://doi.org/10.1053/euhj.2002.3232 CrossRefPubMed

19.

Wilton SB, Leung AA, Ghali WA et al (2011) Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 8:1088–1094. https://doi.org/10.1016/j.hrthm.2011.02.014 CrossRefPubMed

20.

Tang ASL, Wells GA, Talajic M et al (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395. https://doi.org/10.1056/NEJMoa1009540 CrossRefPubMed

21.

Brignole M, Botto GL, Mont L et al (2012) Predictors of clinical efficacy of “Ablate and Pace” therapy in patients with permanent atrial fibrillation. Heart 98:297–302. https://doi.org/10.1136/heartjnl-2011-301069 CrossRefPubMed

22.

Ganesan AN, Brooks AG, Roberts-Thomson KC et al (2012) Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol 59:719–726. https://doi.org/10.1016/j.jacc.2011.10.891 CrossRefPubMed

23.

Gasparini M, Auricchio A, Metra M et al (2008) Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 29:1644–1652. https://doi.org/10.1093/eurheartj/ehn133 CrossRefPubMedPubMedCentral

24.

Hayes DL, Boehmer JP, Day JD et al (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8:1469–1475. https://doi.org/10.1016/j.hrthm.2011.04.015 CrossRefPubMed

25.

Benz AP, Vamos M, Erath JW et al (2018) ICD lead type and RV lead position in CRT-D recipients. Clin Res Cardiol 107:1122–1130. https://doi.org/10.1007/s00392-018-1286-3 CrossRefPubMed

26.

Schiedat F, Schöne D, Aweimer A et al (2019) Multipoint left ventricular pacing with large anatomical separation improves reverse remodeling and response to cardiac resynchronization therapy in responders and non-responders to conventional biventricular pacing. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01499-7 CrossRefPubMed

27.

Raatikainen MJP, Arnar DO, Merkely B et al (2017) A Decade of information on the use of cardaic implantable electronic devices and interventional electrophysiological procedures in the European Society of cardiology countries: 2017 report from the European heart rhythm association. Europace 19:ii1–ii90. https://doi.org/10.1093/europace/eux25 CrossRefPubMed

28.

Curtis AB, Worley SJ, Adamson PB et al (2013) Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 368:1585–1593. https://doi.org/10.1056/NEJMoa1210356 CrossRefPubMed

29.

Ruschitzka F, Abraham WT, Singh JP et al (2013) Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med 369:1395–1405. https://doi.org/10.1056/NEJMoa1306687 CrossRefPubMed

30.

Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15:1070–1118. https://doi.org/10.1093/europace/eut206 CrossRefPubMed

31.

Herold R, Hoffmann W, van den Berg N (2018) Telemedical monitoring of patients with chronic heart failure has a positive effect on total health costs. BMC Health Serv Res. https://doi.org/10.1186/s12913-018-3070-5 CrossRefPubMedPubMedCentral

32.

Hindricks G, Taborsky M, Glikson M et al (2014) Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 384:583–590. https://doi.org/10.1016/S0140-6736(14)61176-4 CrossRefPubMed

33.

Geller JC, Lewalter T, Bruun NE et al (2019) Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01447-5 CrossRefPubMedPubMedCentral

Titel: Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II
verfasst von: Dennis Lawin
Carsten W. Israel
Cecilia Linde
Camilla Normand
Kenneth Dickstein
Christiane Lober
Anselm K. Gitt
Gerhard Hindricks
Christoph Stellbrink
for the members of the European CRT Survey II of the EHRA/HFA/ESC
Publikationsdatum: 06.12.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Research in Cardiology / Ausgabe 7/2020
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-019-01574-z

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II

Abstract

Introduction

Methods and results

Conclusion

Graphic abstract

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

Update Kardiologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Introduction

Methods and results

Conclusion

Graphic abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2020

Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study

Regression of cardiac amyloid load documented by cardiovascular magnetic resonance in a patient with hereditary amyloidosis

Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation

Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry

The association of conventionally medicated systolic and diastolic blood pressure level and mortality from cardiovascular disease: is the lower the better in high stroke population?

Early and late risk of ischemic stroke after TAVR as compared to a nationwide background population

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

Update Kardiologie